Tirzepatide is a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://ammarjqts705951.howeweb.com/41191280/tirzepatide-a-game-changer-for-type-2-diabetes